Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
|Parkinson's Disease Multiple System Atrophy Orthostatic Hypotension||Drug: Fludrocortisone Drug: Domperidone Behavioral: Conservative Measures for Orthostatic Hypotension||Phase 1|
|Study Design:||Allocation: Randomized
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy|
- Efficacy of conservative treatment, domperidone, and fludrocortisone for patient's subjective symptoms of orthostatic hypotension, and on objective autonomic testing
|Study Start Date:||January 2005|
|Estimated Study Completion Date:||September 2005|
Enrolled patients, ages 40-95, must have Parkinson's or MSA, diagnosed by a neurologist, and symptoms of orthostatic hypotension. Each patient will fill out two validated questionnaires to determine if they are candidates for the study. Baseline patient details, such as their medications and UPDRS, will be recorded. Medications must be held stable during the period of the study.
Each patient will then have three weeks of conservative therapy, three weeks of therapy with fludrocortisone, and three weeks of therapy with domperidone. Autonomic testing, a symptom questionnaire, bedside blood pressure testing, and UPDRS will be performed after each intervention.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00103597
|Royal Brisbane and Women's Hospital|
|Brisbane, Queensland, Australia, 4029|
|Principal Investigator:||Kerrie Schoffer, MBBS||Movement Disorders Fellow|